# A Multiple Dose Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04457845 in Healthy Volunteers

> **NCT00836082** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 41 (actual)

## Conditions studied

- Acute Pain
- Chronic Pain

## Interventions

- **DRUG:** PF-04457845, FAAH inhibitor
- **DRUG:** PF-04457845, FAAH inhibitor
- **DRUG:** PF-04457845, FAAH inhibitor
- **DRUG:** PF-04457845, FAAH inhibitor
- **DRUG:** PF-04457845, FAAH inhibitor
- **DRUG:** PF-04457845, FAAH inhibitor

## Key facts

- **NCT ID:** NCT00836082
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2009-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00836082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00836082, "A Multiple Dose Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04457845 in Healthy Volunteers". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00836082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*